cloudfront

Report Detail

Pharma & HealthcareGlobal Brucellosis Vaccines Market Insights, Forecast to 2025

  • RnM2459689
  • |
  • 15 March, 2019
  • |
  • Global
  • |
  • 129 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Brucellosis Vaccines Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Brucellosis Vaccines Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Brucellosis Vaccines Market Size Growth Rate by Product
      • 1.4.2 S19 Vaccine
      • 1.4.3 RB51 Vaccine Strain
      • 1.4.4 Other
    • 1.5 Market by End User
      • 1.5.1 Global Brucellosis Vaccines Market Size Growth Rate by End User
      • 1.5.2 Cattle
      • 1.5.3 Sheep
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Brucellosis Vaccines Market Size
      • 2.1.1 Global Brucellosis Vaccines Revenue 2014-2025
      • 2.1.2 Global Brucellosis Vaccines Sales 2014-2025
    • 2.2 Brucellosis Vaccines Growth Rate by Regions
      • 2.2.1 Global Brucellosis Vaccines Sales by Regions
      • 2.2.2 Global Brucellosis Vaccines Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Brucellosis Vaccines Sales by Manufacturers
      • 3.1.1 Brucellosis Vaccines Sales by Manufacturers
      • 3.1.2 Brucellosis Vaccines Sales Market Share by Manufacturers
      • 3.1.3 Global Brucellosis Vaccines Market Concentration Ratio (CR5 and HHI)
    • 3.2 Brucellosis Vaccines Revenue by Manufacturers
      • 3.2.1 Brucellosis Vaccines Revenue by Manufacturers (2014-2019)
      • 3.2.2 Brucellosis Vaccines Revenue Share by Manufacturers (2014-2019)
    • 3.3 Brucellosis Vaccines Price by Manufacturers
    • 3.4 Brucellosis Vaccines Manufacturing Base Distribution, Product Types
      • 3.4.1 Brucellosis Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Brucellosis Vaccines Product Type
      • 3.4.3 Date of International Manufacturers Enter into Brucellosis Vaccines Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Brucellosis Vaccines Sales by Product
    • 4.2 Global Brucellosis Vaccines Revenue by Product
    • 4.3 Brucellosis Vaccines Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Brucellosis Vaccines Breakdown Data by End User

    6 North America

    • 6.1 North America Brucellosis Vaccines by Countries
      • 6.1.1 North America Brucellosis Vaccines Sales by Countries
      • 6.1.2 North America Brucellosis Vaccines Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Brucellosis Vaccines by Product
    • 6.3 North America Brucellosis Vaccines by End User

    7 Europe

    • 7.1 Europe Brucellosis Vaccines by Countries
      • 7.1.1 Europe Brucellosis Vaccines Sales by Countries
      • 7.1.2 Europe Brucellosis Vaccines Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Brucellosis Vaccines by Product
    • 7.3 Europe Brucellosis Vaccines by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Brucellosis Vaccines by Countries
      • 8.1.1 Asia Pacific Brucellosis Vaccines Sales by Countries
      • 8.1.2 Asia Pacific Brucellosis Vaccines Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Brucellosis Vaccines by Product
    • 8.3 Asia Pacific Brucellosis Vaccines by End User

    9 Central & South America

    • 9.1 Central & South America Brucellosis Vaccines by Countries
      • 9.1.1 Central & South America Brucellosis Vaccines Sales by Countries
      • 9.1.2 Central & South America Brucellosis Vaccines Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Brucellosis Vaccines by Product
    • 9.3 Central & South America Brucellosis Vaccines by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Brucellosis Vaccines by Countries
      • 10.1.1 Middle East and Africa Brucellosis Vaccines Sales by Countries
      • 10.1.2 Middle East and Africa Brucellosis Vaccines Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Brucellosis Vaccines by Product
    • 10.3 Middle East and Africa Brucellosis Vaccines by End User

    11 Company Profiles

    • 11.1 Jinyu
      • 11.1.1 Jinyu Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Jinyu Brucellosis Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Jinyu Brucellosis Vaccines Products Offered
      • 11.1.5 Jinyu Recent Development
    • 11.2 Colorado Serum
      • 11.2.1 Colorado Serum Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Colorado Serum Brucellosis Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Colorado Serum Brucellosis Vaccines Products Offered
      • 11.2.5 Colorado Serum Recent Development
    • 11.3 Boehringer Ingelheim
      • 11.3.1 Boehringer Ingelheim Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Boehringer Ingelheim Brucellosis Vaccines Products Offered
      • 11.3.5 Boehringer Ingelheim Recent Development
    • 11.4 Biogenesis-Bago
      • 11.4.1 Biogenesis-Bago Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Biogenesis-Bago Brucellosis Vaccines Products Offered
      • 11.4.5 Biogenesis-Bago Recent Development
    • 11.5 Vetal Company
      • 11.5.1 Vetal Company Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Vetal Company Brucellosis Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Vetal Company Brucellosis Vaccines Products Offered
      • 11.5.5 Vetal Company Recent Development
    • 11.6 CZ Veterinaria
      • 11.6.1 CZ Veterinaria Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 CZ Veterinaria Brucellosis Vaccines Products Offered
      • 11.6.5 CZ Veterinaria Recent Development
    • 11.7 SYVA Laboratorios
      • 11.7.1 SYVA Laboratorios Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 SYVA Laboratorios Brucellosis Vaccines Products Offered
      • 11.7.5 SYVA Laboratorios Recent Development
    • 11.8 Indian Immunologicals
      • 11.8.1 Indian Immunologicals Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Indian Immunologicals Brucellosis Vaccines Products Offered
      • 11.8.5 Indian Immunologicals Recent Development
    • 11.9 Qilu
      • 11.9.1 Qilu Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Qilu Brucellosis Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Qilu Brucellosis Vaccines Products Offered
      • 11.9.5 Qilu Recent Development
    • 11.10 Tecnovax
      • 11.10.1 Tecnovax Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Tecnovax Brucellosis Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Tecnovax Brucellosis Vaccines Products Offered
      • 11.10.5 Tecnovax Recent Development
    • 11.11 Hester Biosciences
    • 11.12 Zoetis
    • 11.13 Onderstepoort Biological
    • 11.14 Instituto Rosenbusch
    • 11.15 Ceva Sante Animale
    • 11.16 Calier & Biologicos Laverlam
    • 11.17 Biovet

    12 Future Forecast

    • 12.1 Brucellosis Vaccines Market Forecast by Regions
      • 12.1.1 Global Brucellosis Vaccines Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Brucellosis Vaccines Revenue Forecast by Regions 2019-2025
    • 12.2 Brucellosis Vaccines Market Forecast by Product
      • 12.2.1 Global Brucellosis Vaccines Sales Forecast by Product 2019-2025
      • 12.2.2 Global Brucellosis Vaccines Revenue Forecast by Product 2019-2025
    • 12.3 Brucellosis Vaccines Market Forecast by End User
    • 12.4 North America Brucellosis Vaccines Forecast
    • 12.5 Europe Brucellosis Vaccines Forecast
    • 12.6 Asia Pacific Brucellosis Vaccines Forecast
    • 12.7 Central & South America Brucellosis Vaccines Forecast
    • 12.8 Middle East and Africa Brucellosis Vaccines Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Brucellosis Vaccines Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.
      The classification of Brucellosis Vaccines includes S19 Vaccine, RB51 Vaccine Strain and Other. And the proportion of S19 Vaccine in 2016 is about 86%, and the proportion is stable from 2012 to 2016.
      Brucellosis Vaccines is widely used in Cattle, Sheep and Other Animal. The most proportion of Brucellosis Vaccines is for Cattle with market share about 60 in 2016.
      China is the largest supplier of Brucellosis Vaccines, with a production market share nearly 31% in 2016. Europe is the second largest supplier of Brucellosis Vaccines, enjoying production market share nearly 17% in 2016.
      China is the largest consumption place, with a consumption market share nearly 31% in 2016. Following China, South America is the second largest consumption place with the consumption market share of 17%.
      The global Brucellosis Vaccines market is valued at 10 million US$ in 2018 and will reach 13 million US$ by the end of 2025, growing at a CAGR of 3.7% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Brucellosis Vaccines market based on company, product type, end user and key regions.

      This report studies the global market size of Brucellosis Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Brucellosis Vaccines in these regions.
      This research report categorizes the global Brucellosis Vaccines market by top players/brands, region, type and end user. This report also studies the global Brucellosis Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Jinyu
      Colorado Serum
      Boehringer Ingelheim
      Biogenesis-Bago
      Vetal Company
      CZ Veterinaria
      SYVA Laboratorios
      Indian Immunologicals
      Qilu
      Tecnovax
      Hester Biosciences
      Zoetis
      Onderstepoort Biological
      Instituto Rosenbusch
      Ceva Sante Animale
      Calier & Biologicos Laverlam
      Biovet

      Market size by Product
      S19 Vaccine
      RB51 Vaccine Strain
      Other
      Market size by End User
      Cattle
      Sheep
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Brucellosis Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Brucellosis Vaccines market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Brucellosis Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Brucellosis Vaccines submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Brucellosis Vaccines are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (M Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Brucellosis Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.




      Summary:
      Get latest Market Research Reports on Brucellosis Vaccines . Industry analysis & Market Report on Brucellosis Vaccines is a syndicated market report, published as Global Brucellosis Vaccines Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Brucellosis Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      2,618.85
      3,928.28
      5,237.70
      3,588.78
      5,383.17
      7,177.56
      472,446.00
      708,669.00
      944,892.00
      258,622.26
      387,933.39
      517,244.52
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report